Scare tactics have been around since as long as we can remember. It's a proven technique that boost sales. Lots of successful marketing campaigns have centered around peoples fear. Smart right? Use peoples fears and insecurities so they buy and use the product. Well when people are buying drugs they don't necessarily need there are repercussions. There are side effects to these drugs, there are cost effects, and it encourages more of this vicious cycle. Drug safety is big issue and people are abusing their drugs and pharma doesn't mind because it's more money for them. Low Dose Naltrexone may not be right for you, but there's a pretty good chance it will help treat your disease. And for about a dollar a day, we want to scare you off your other drugs and consider LDN. This is our scare tactic.
“Pharma is hardly the only industry that sells products to help people protect their health that preys on people’s worries about their health," according to David Ropiek, a Harvard instructor . One reason for the potential increase in pharma's use of fear tactics? These days, it's harder to get people's attention, given the growing number of media sources. So in advertising--as well as in the news media itself--"more attention-getting approaches are certainly proliferating,” he said. One thing the recent ads all have in common: They're disease awareness ads that don't promote specific products. Still, using fear as a motivator can also create a negative backlash, both from the media and consumers, whether it is branded work or disease awareness.